17 Mar 2026 16:54
17 March 2026
Β
RUA Life Sciences plc
("RUA" the "Company" or the "Group")
Β
Result of AGM
RUA Life Sciences plcΒ (AIM:RUA), the holding company of a group of medical device businesses focused on implantable textiles and the leading biostable polymer (Elast-Eonβ’), announces that all resolutions put forward to its Annual General Meeting held earlier today were duly passed, and the votes cast were as follows:
Β
Res No. | Votes For | % | Votes Against | % | Votes Total | % V.C. | Votes Withheld |
01 | 6,996,885 | 98.88% | 78,936 | 1.12% | 7,075,821 | 11.40 | 0 |
02 | 6,962,437 | 98.41% | 112,576 | 1.59% | 7,075,013 | 11.40 | 808 |
03 | 6,995,836 | 98.88% | 79,177 | 1.12% | 7,075,013 | 11.40 | 808 |
04 | 7,010,744 | 99.08% | 65,077 | 0.92% | 7,075,821 | 11.40 | 0 |
05 | 7,010,744 | 99.08% | 65,077 | 0.92% | 7,075,821 | 11.40 | 0 |
06 | 6,963,273 | 98.88% | 78,936 | 1.12% | 7,042,209 | 11.35 | 33,612 |
07 | 6,963,273 | 98.41% | 112,548 | 1.59% | 7,075,821 | 11.40 | 0 |
08 | 6,996,885 | 98.88% | 78,936 | 1.12% | 7,075,821 | 11.40 | 0 |
09 | 6,963,273 | 98.41% | 112,548 | 1.59% | 7,075,821 | 11.40 | 0 |
10 | 7,010,716 | 99.08% | 65,105 | 0.92% | 7,075,821 | 11.40 | 0 |
11 | 6,907,147 | 97.62% | 168,579 | 2.38% | 7,075,726 | 11.40 | 95 |
12 | 6,907,147 | 97.62% | 168,579 | 2.38% | 7,075,726 | 11.40 | 95 |
13 | 6,907,360 | 97.62% | 168,366 | 2.38% | 7,075,726 | 11.40 | 95 |
14 | 6,957,401 | 98.33% | 118,365 | 1.67% | 7,075,766 | 11.40 | 55 |
Β
The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the Company's website (www.rualifesciences.com).
Β
For further information contact:
RUA Life Sciences | Tel: +44 (0)1294 317073 |
Bill Brown, CEO | |
Lachlan Smith, CFO | |
Cavendish Capital Markets Limited | Tel: +44 (0)20 7220 0500 |
(Nominated Adviser and Broker) | |
Giles Balleny/Isaac Hooper (Corporate Finance) | |
Harriet Ward (Broking) | |
Nigel Birks (Healthcare Specialist Sales) | |
Michael Johnson (Sales) |
Β
Follow the stocks